Semaglutide Showdown: FDA and Big Pharma Take On Compounders
The battle over semaglutide, the active ingredient in popular diabetes and weight loss drugs, has reached a critical point. A federal judge in Texas recently ruled against compounding pharmacies, siding with a major drug manufacturer. This decision means that these pharmacies can no longer produce c